|
Volumn 16, Issue 3, 2002, Pages 438-440
|
Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ENDOTHELIAL NITRIC OXIDE SYNTHASE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
IMMUNOGLOBULIN G;
INTERCELLULAR ADHESION MOLECULE 1;
MELOXICAM;
MEMBRANE RECEPTOR;
NITRIC OXIDE SYNTHASE;
NONSTEROID ANTIINFLAMMATORY AGENT;
NOS3 PROTEIN, RAT;
PROSTAGLANDIN SYNTHASE INHIBITOR;
THIAZINE DERIVATIVE;
THIAZOLE DERIVATIVE;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
ANIMAL;
ARTICLE;
BIOLOGICAL MODEL;
BLOOD;
BLOOD RETINA BARRIER;
CELL ADHESION;
DIABETIC RETINOPATHY;
DRUG EFFECT;
IMMUNOLOGY;
KINETICS;
LONG EVANS RAT;
METABOLISM;
NEUTROPHIL;
RAT;
RETINA;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ASPIRIN;
BLOOD-RETINAL BARRIER;
CELL ADHESION;
CYCLOOXYGENASE INHIBITORS;
DIABETIC RETINOPATHY;
IMMUNOGLOBULIN G;
INTERCELLULAR ADHESION MOLECULE-1;
KINETICS;
MODELS, BIOLOGICAL;
NEUTROPHILS;
NF-KAPPA B;
NITRIC OXIDE SYNTHASE;
NITRIC OXIDE SYNTHASE TYPE III;
RATS;
RATS, LONG-EVANS;
RECEPTORS, LEUKOCYTE-ADHESION;
RECEPTORS, TUMOR NECROSIS FACTOR;
RETINA;
THIAZINES;
THIAZOLES;
TUMOR NECROSIS FACTOR-ALPHA;
MLCS;
MLOWN;
|
EID: 0036517850
PISSN: None
EISSN: 15306860
Source Type: Journal
DOI: 10.1096/fj.01-0707fje Document Type: Article |
Times cited : (524)
|
References (0)
|